Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research.
The SEP identified priorities to support in future basic and clinical research and pointed out directions likely to result in advances against heart failure. The list is not intended to be all-encompassing and does not address, for example, exciting lines of work already under way. Rather, the recommendations are designed to point out gaps in current knowledge not being adequately addressed and highly promising new directions. Although the incidence of heart failure continues to grow, emerging lines of research provide hope that research advances will eventually lead to more effective treatment and ultimately to prevention. This research will be well served by bringing the latest multidisciplinary approaches and the best investigators to focus on the problems of heart failure. It is hoped the efforts of distinguished expert entities such as the task force and SEP will be a useful guide in addressing the needs of the biomedical community and assisting in its success.
Cohn
J N
JN
National Heart, Lung, and Blood Institute, Rockledge Center Two, Bethesda, MD 20892, USA.
Bristow
M R
MR
Chien
K R
KR
Colucci
W S
WS
Frazier
O H
OH
Leinwand
L A
LA
Lorell
B H
BH
Moss
A J
AJ
Sonnenblick
E H
EH
Walsh
R A
RA
Mockrin
S C
SC
Reinlib
L
L
D000818:Animals; D017209:Apoptosis; D002453:Cell Cycle; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006321:Heart / Q000502:physiology / Q000503:physiopathology; D006333:Heart Failure / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D009206:Myocardium / Q000166:cytology; D009316:National Institutes of Health (U.S.); D012106:Research / Q000639:trends*; D014481:United States